Amplification of genomic DNA demonstrates the presence of the t(2;5)(p23;q35) in anaplastic large cell lymphoma, but not in other non- Hodgkin's lymphomas, Hodgkin's disease, or lymphomatoid papulosis

Blood

Volumn 88, Issue 5, 1996, Pages 1771-1779

  Sarris, Andreas H ^a   Luthra, Rajyalakshmi ^b   Papadimitracopoulou, Valli ^b   Waasdorp, Mimi ^b   Dimopoulos, Meletios A ^b   McBride, J A ^b   Cabanillas, Fernando ^b   Duvic, Madeleine ^b   Deisseroth, Albert ^b   Morris, Stephan W ^b   Pugh, William C ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLOBIN; CD30 ANTIGEN; INTERLEUKIN 2 RECEPTOR; NUCLEOPHOSMIN; OLIGONUCLEOTIDE; PROTEIN KINASE;

ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CHILD; CHROMOSOME 5; CHROMOSOME TRANSLOCATION 2; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE REARRANGEMENT; HODGKIN DISEASE; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL LYMPHOMA; LYMPHOMATOID PAPULOSIS; MALE; MINIMAL RESIDUAL DISEASE; NONHODGKIN LYMPHOMA; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS;

EID: 9544248673     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.5.1771.1771     Document Type: Article

References (57)

1. Stein H, Mason DY, Gerdes J, O'Connor N, Wainscoat J, Pallesen G, Gatter K, Falini B, Delsol G, Lemke H, Schwarting R, Lennert K: The expression of the Hodgkin's disease associated antigen Ki-1 in reactive and neoplastic lymphoid tissue: Evidence that Reed-Sternberg cells and histiocytic malignancies are derived from activated lymphoid cells. Blood 66:848, 1985
2. Stansfeld AG, Diebold J, Noel H, Kapanci Y, Rilke F, Kelenyi G, Sundstrom C, Lennert K, vanUnnik JAM, Mioduszewska O, Wright DH: Updated Kiel classification for lymphomas. Lancet 1:292, 1988
3. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JK, Cleary ML, Delsol G, De Wolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink H-K, Pileri SA, Piris MA, Ralfkiaer E, Warnke R: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 84:1361, 1994
4. Greer JP, Kinney MC, Collins RD, Salhany KE, Wolff SN, Hainsworth JD, Flexner JM, Stein RS: Clinical features of 31 patients with Ki-1 anaplastic large-cell lymphoma. J Clin Oncol 9:539, 1991
5. Chott A, Kaserer K, Augustin I, Vesely M, Heinz R, Oehlinger W, Hanak H, Radaszkiewicz T: Ki-1-positive large cell lymphoma. A clinicopathologic study of 41 cases. Am J Surg Pathol 14:439, 1990
6. Chan JK, Ng CS, Hui PK, Leung TW, Lo ES, Lau WH, McGuire LJ: Anaplastic large cell Ki-1 lymphoma. Delineation of two morphological types. Histopathology 15:11, 1989
7. Kinney MC, Collins RD, Greer JP, Whitlock JA, Sioutos N, Kadin ME: Small-cell-predominant variant of primary Ki-1 (CD30)+ T-cell lymphoma. Am J Surg Pathol 17:859, 1993
8. Pileri S, Falini B, Delsol G, Stein H, Baglioni P, Poggi S, Martelli MF, Rivano MT, Mason DY, Stansfeld AG: Lymphohistiocytic T-cell lymphoma (anaplastic large cell lymphoma CD30+/ Ki-1+ with a high content of reactive histiocytes). Histopathology 16:383, 1990
9. Chan JK, Buchanan R, Fletcher CD: Sarcomatoid variant of anaplastic large-cell I Ki-1 lymphoma. Am J Surg Pathol 14:983, 1990
10. Kinney MC, Glick AD, Stein H, Collins RD: Comparison of anaplastic large cell Ki-1 lymphomas and microvillous lymphomas in their immunologic and ultrastructural features. Am J Surg Pathol 14:1047, 1990
11. Pileri S, Bocchia M, Baroni CD, Martelli M, Falini B, Sabattini E, Gherlinzoni F, Amadori S, Poggi S, Mazza P, Burgio V, Zinzani PL, Melilli G, Benni M, Savagoni L, Martelli M, Stein H, Mandelli F, Tura S: Anaplastic large cell lymphoma (CD30+/Ki-1+): Results of a prospective clinico-pathological study of 69 cases. Br J Haematol 86:513, 1994
12. Stein H, Herbst H, Anagnostopoulos I, Niedobitek G, Dallenbach F, Kratzsch HC: The nature of Hodgkin and Reed-Sternberg cells, their association with EBV, and their relationship to anaplastic large-cell lymphoma. Ann Oncol 2:33, 1991
13. Kaudewitz P, Stein H, Dallenbach F, Eckert F, Bieber K, Burg G, Braun-Falco O: Primary and secondary cutaneous Ki-1 + (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics. Am J Pathol 135:359, 1989
14. Cabanillas F, Armitage J, Pugh WC, Weisenburger D, Duvic M: Lymphomatoid papulosis: A T-cell dyscrasia with a propensity to transform into malignant lymphoma. Ann Intern Med 122:210, 1995
15. Bitter MA, Franklin WA, Larson RA, McKeithan TW, Rubin CM, Le BM, Stephens JK, Vardiman JW: Morphology in Ki-1 (CD30)-positive non-Hodgkin's lymphoma is correlated with clinical features and the presence of a unique chromosomal abnormality, t(2;5)(p23;q35). Am J Surg Pathol 14:305, 1990
16. Schwab U, Stein H, Gerdes J, Lemke H, Kirchner H, Schaadt M, Diehl V: Production of a monoclonal antibody specific for Hodgkin and Sternberg-Reed cells of Hodgkin's disease and a subset of normal lymphoid cells. Nature 299:65, 1982
17. Durkop H, Latza U, Hummel M, Eitelbach F, Seed B, Stein H: Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease. Cell 68:421, 1992, p 675
18. Smith CA, Gruss HJ, Davis T, Anderson D, Farrah T, Baker E, Sutherland GR, Brannan CI, Copeland NG, Jenkins NA, Grabstein KH, Gliniak B, B. MI, Fanslow W, Alderson M, Falk B, Gimpel S, Gillis S, Goodwin RG, Armitage RJ: CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 73:1349, 1993
19. Stein H, Dallenbach F: Diffuse large cell lymphomas of B and T cell type, in Knowles DM (ed): Neoplastic Hematopathology. Baltimore, MD, Williams & Wilkins, 1992, p 675
20. Pinto A, Gloghini A, Gattei V, Aldinucci D, Zagonel V, Carbone A: Expression of the c-kit receptor in human lymphomas is restricted to Hodgkin's disease and CD30+ anaplastic large cell lymphomas. Blood 83:785, 1994
21. Inghirami G, Macri L, Cesarman E, Chadburn A, Zhong J, Knowles DM: Molecular characterization of CD30+ anaplastic large-cell lymphoma: High frequency of c-myc proto-oncogene activation. Blood 83:3581, 1994
22. Leoncini L, Del Vecchio MT, Kraft R, Megha T, Barbini P, Cevenini G, Poggi S, Pileri S, Tosi P, Cottier H: Hodgkin's disease and CD30-postlive anaplastic large cell lymphomas a continuous spectrum of malignant disorders. A quantitative morphometric and immunohistologic study. Am J Pathol 137:1047, 1990
23. Davis TH, Morton CC, Miller-Cassman R, Balk SP, Kadin ME: Hodgkin's disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone. N Engl J Med 326:1115, 1992
24. Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME, Vardiman JW: The t(2;5)(p23;q35): A recurring chromosomal abnormality in Ki-1-positive anaplastic large cell lymphoma. Leukemia 3:866, 1989
25. Mason DY, Bastard C, Rimokh R, Dastugue N, Huret JL, Kristoffersson U, Magaud JP, Nezelof C, Tilly H, Vannier JP, Hemet J, Wamke R: CD30-positive large cell lymphomas ('Ki-1 lymphoma') are associated with a chromosomal translocation involving 5q35 [see comments]. Br J Haematol 74:161, 1990
26. Offit K, Ladanyi M, Gangi MD, Ebrahim SA, Filippa D, Chaganti RS: Ki-1 antigen expression defines a favorable clinical subset of non-B cell non-Hodgkin's lymphoma. Leukemia 4:625, 1990
27. Sandlund JT, Pui CH, Roberts WM, Santana VM, Morris SW, Berard CW, Hutchison RE, Ribeiro RC, Mahmoud H, Crist WM, Heim M, Raimondi SC: Clinicopathologic features and treatment outcome of children with large-cell lymphoma and the t(2;5)(p23;q35). Blood 84:2467, 1994
28. Morris SW, Kirstein MN, Valentine MB, Dittmer KG, Shapiro DN, Saltman DL, Look AT: Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma. Science 263:1281, 1994
29. Borer RA, Lehner CF, Eppenberger HM, Nigg EA: Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 56:379, 1989
30. Chan WY, Liu QR, Borjigin J, Busch H, Rennert OM, Tease LA, Chan PK: Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth. Biochemistry 28:1033, 1989
31. Shiota M, Fujimoto J, Semba T, Satoh H, Yamamoto T, Mori S: Hyperphosphorylation of a novel 80 kDa protein-tyrosine kinase similar to Ltk in a human Ki-1 lymphoma cell line, AMS3. Oncogene 9:1567, 1994
32. Shiota M, Fujimoto J, Takenaga M, Salon H, Ichinohasama R, Abe M, Nakano M, Yamamoto T, Mori S: Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry. Blood 84:3648, 1994
33. Waggott W, Lo Y-MD, Bastard C, Gatter KC, Leroux D, Mason DY, Boultwood J, Wainscoat JS: Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma. Br J Haematol 89:905, 1995
34. Morgan R, Smith SD, Hecht BK, Christy V, Mellentin JD, Warnke R, Cleary ML: Lack of involvement of the c-fms and N-myc genes by chromosomal translocation t(2;5)(p23;q35) common to malignancies with features of so-called malignant histiocytosis. Blood 73:2155, 1989
35. Fischer P, Nacheva E, Mason DY, Sherrington PD, Hoyle C, Hayhoe FG, Karpas A: A Ki-1 (CD30)-positive human cell line (Karpas 299) established from a high-grade non-Hodgkin's lymphoma, showing a 2; 5 translocation and rearrangement of the T-cell receptor beta-chain gene. Blood 72:234, 1988
36. Sambrook J, Fritsch EF, Maniatis T: Molecular cloning. A laboratory manual. Plainview, NY, Cold Spring Harbor Laboratory Press, 1989
37. Pileri SA, Piccaluga A, Poggi S, Sabatini E, Piccalugga PP, De Vivo A, Falini B, Stein H: Anaplastic large cell lymphoma: Update of findings. Leuk Lymphoma 18:17, 1995
38. Lukes RJ, Butler JJ: The pathology and nomenclature of Hodgkin's disease. Cancer Res 26:1063, 1966
39. Bullrich F, Morris SW, Hummel M, Pileri S, Stein H, Croce CM: Nucleophosmin (NPM) gene rearrangements in Ki-1-positive lymphomas. Cancer Res 54:2873, 1994
40. Sealey PG, Whittaker PA, Southern EM: Removal of repeated sequences from hybridisation probes. Nucleic Acids Res 13:1905, 1985
41. Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M: Report of the Committee on Hodgkin's Disease Staging Classification. Cancer Res 31:1860, 1971
42. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329:987, 1993
43. Downing J, Shurtleff S, Head D, Behm F, Raimondi S, Weisenburger D, Kossakowska A, Thorner P, Zielenski M, Lorenzana A, Ladanyi M, Morris S: Molecular detection of t(2;5) of non-Hodgkin's lymphoma by reverse transcriptase polymerase chain reaction (RT-PCR). Mod Pathol 8:109A, 1995 (abstr)
44. Lopetagui JR, Sun LH, Chan KC, Gaffey MJ, Frierson HF, Kamel OW, Koo C, Glaskin C, Weiss LM: Association of t(2:5) in CD30-positive anaplastic large cell lymphoma vs Hodgkin's disease. Mod Pathol 8:115A, 1995 (abstr)
45. Ngan B: The presence of transcripts of the fusion of kinase gene ALK to nucleophosmin gene NPM in the t(2;5)(p23;q35) translocation defines subsets of non-Hodgkin's lymphoma with or without CD30 (Ki-1 ) expression and Hodgkin's disease. Mod Pathol 8:118A, 1995 (abstr)
46. Wellmann A, Clark HM, Otsuki T, Jaffe ES, Raffeld M: Detection of the t(2;5)(p23;q35) in classical anaplastic large cell lymphoma (ALCL) by reverse transcriptase-polymerase chain reaction. Mol Pathol 8:123A, 1995 (abstr)
47. Wellmann A, Otsuki T, Vogelbruch M, Clark HM, Jaffe ES, Raffeld M: Analysis of the t(2;5)(p23;q35) translocation by reverse transcription-polymerase chain reaction in CD30+ anaplastic large-cell lymphomas, in other non-Hodgkin's lymphomas of T-cell phenotype, and in Hodgkin's disease. Blood 86:2321, 1995
48. Yee HT, Ponzoni M, Merson A, Scarpa A, Menestrina F, Chilosi M, Pittaluga S, DeWolf-Peeters C, Frizzera G, Ighirami G: Chimeric NPM-ALK transcripts of t(2;5) in anaplastic large cell lymphoma (ALCL) and Hodgkin's disease (HD). Mod Pathol 8:124A, 1995 (abstr)
49. Orscheschek K, Merz H, Hell J, Binder T, Bartels H, Feller AF: Large-cell anaplastic lymphoma-specific translocation (t[2;5]-p23;q35]) in Hodgkin's disease: Indication of a common pathogenesis? Lancet 345:87, 1995
50. Herbst H, Anagnostopoulos J, Heinze B, Dürkop H, Hummel M, Stein H: ALK gene products in anaplastic large cell lymphomas and Hodgkin's disease. Blood 86:1694, 1995
51. Downing JR, Shurtleff SA, Zielenska M, Curcio-Brint AM, Behm FG, Head DR, Sandlund JT. Weisenburger DD, Kossakowska AE, Thorner P, Lorenzana A, Ladanyi M, Morris SW: Molecular detection of the (2;5) translocation of non-Hodgkin's lymphoma by reverse transcriptase-polymerase chain reaction. Blood 85:3416, 1995
52. Shiota M, Nakamura S, Ichinohasama R, Abe M, Akagi T, Takeshita M, Mori N, Fujimoto J, Miyauchi J, Mikata A, Nanba K, Takami T, Yamabe H, Takano Y, Izumo T, Nagatani T, Mohri N, Nasu K, Satoh H, Katano H, Fujimoto J, Yamamoto T. Mori S: Anaplastic large cell lymphomas expressing the novel chimeric protein p80 NPM/ALK: A distinct clinicopathologic entity. Blood 86:1954, 1995
53. Elmberger PG, Lozano MD, Weisenburger DD, Sanger W, Chan WC: Transcripts of the npm-alk fusion gene in anaplastic large cell lymphoma, Hodgkin's disease, and reactive lymphoid lesions. Blood 86:3517, 1995
54. Lamant L, Meggetto F, Al Saati T, Brugieres L, Bressac de Paillerets B. Dastugue N, Bernheim A, Rubie H, Terrier-Lacombe MJ, Robert A, Brousset P, Rigal F, Schlaifer D, Shiota M, Mori S, Deisol G: High incidence of the t(2;5)(p23;q35) translocation in anaplastic large cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis, reverse transcriptase-polymerase chain reaction, and p-80 immunostaining. Blood 87:284, 1996
55. Gordon BG, Weisenburger DD, Warkentin PI, Anderson J, Sanger WG, Bast M, Gnarra D, Vose JM, Bierman PJ, Armitage JO, Coccia PF: Peripheral T-cell lymphoma in childhood and adolescence. A clinicopathologic study of 22 patients. Cancer 71:257, 1993
56. Weiss LM, Lopategue JR, Sun L-H, Kamel OW, Koo CH, Glackin G: Absence of the t(2;5) in Hodgkin's Disease. Blood 85:2845, 1995
57. Morris SW, Shurtleff SA, Head D, Behm FG, Raimondi SC, Weisenburger DD, Kossakowska AE, Thorner P, Zielenski M, Lorenzana A, Ladanyi M, Downing JR: Molecular detection of the 1(2;5) of non-Hodgkin's lymphoma (NHL) by reverse transcriptase-polymerase chain reaction. Blood 84:37a, 1994 (abstr, suppl 1)